Ledger.Open graph →
SEC Form D · filed September 13, 2023

SELKIRK PHARMA, INC

Offering
$25.0M
Sold
$24.1M
Exemption
Rule 506(b)
Industry
Manufacturing
Location
SPOKANE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Patrick Haffey · SPOKANE VALLEY, WAExec · DirectorJoe Herzog · SPOKANE, WAExec · DirectorTom Tobin · SPOKANE, WADirectorRod Raabe · SPOKANE, WADirectorMarshall Crew · SPOKANE, WADirectorPatrick Haffey · SPOKANE VALLEY, WAExec · DirectorJoe Herzog · SPOKANE, WAExec · DirectorMarshall Crew · SPOKANE, WADirectorTom Tobin · SPOKANE, WADirectorRod Raabe · Santa Rosa, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

SELKIRK PHARMA, INC. — SEC Form D filing (2023) | Ledger